Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Treasury tax‑policy nominee Ken Keyes pressed on TCJA permanence, child credit and lobbying ties
Loading...
Summary
Ken Keyes, President Trump’s nominee for assistant secretary of the treasury for tax policy, told senators he supports extending key Tax Cuts and Jobs Act provisions but declined to expand ethics recusal commitments beyond his written agreement.
Ken Keyes, President Trump’s nominee for assistant secretary of the treasury for tax policy, defended his long record in tax policy at a Senate Finance Committee hearing while facing persistent questions about the potential fiscal effects of Republican tax proposals and his past private‑sector clients.
Keyes emphasized his decades of experience and repeated that extending 2017 tax law provisions would preserve larger standard deductions and child tax credits for many families. He said allowing the 2017 changes to expire would cut benefits for a typical family of four and described the TCJA as “a very effective pro growth piece of legislation.” Keyes presented revenue comparisons cited during his testimony: total federal revenues rising from about $3.316 trillion in 2017 to about $4.918 trillion in 2024, and corporate income tax revenue rising from $297 billion in 2017 to $529 billion in 2024.
Democratic senators pressed Keyes on distributional effects and cost. Senator Elizabeth Warren and others cited analyses that large corporate and high‑income taxpayers would receive a disproportionate share of proposed benefits; Warren asked whether Keyes would commit to recusing himself from matters affecting former clients beyond the one‑year ethics recusal he described. Keyes said he would comply with the terms of the career ethics letter and the post‑employment restrictions set by ethics officials. He declined to go beyond the ethics agreement in pledging longer recusal periods while in office.
Lawmakers raised corporate tax avoidance and international tax issues. Senator Sheldon Whitehouse pointed to Pfizer and other firms that report profits offshore; Keyes said reforms in 2017 reduced incentives for inversions and made certain offshore arrangements less attractive, but acknowledged complex transfer‑pricing and international tax questions remain.
Questions also covered scorekeeping and baselines: Keyes explained current policy baselines are one of the tools used to evaluate permanence in the tax code and that the Joint Committee on Taxation follows statutory scoring conventions but will produce current policy estimates when requested by members.
Ending: Keyes will submit written answers for questions on the record; committee action is pending.
